Overview

Combination Chemotherapy in Treating Patients With Sarcoma

Status:
Completed
Trial end date:
2013-10-21
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This clinical trial is studying how well combination chemotherapy works in treating patients with sarcoma.
Phase:
Early Phase 1
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Cancer Institute (NCI)
Treatments:
Cyclophosphamide
Doxorubicin
Etoposide
Ifosfamide
Liposomal doxorubicin
Vincristine